Skip to main content
OpenTrials

Clinical trial condition

Thyroid Eye Disease

Explore clinical trials studying Thyroid Eye Disease. Study availability and eligibility vary by location and protocol.

53 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Thyroid Eye Disease trial results

Completed

Study of ZB001 in Chinese Patients With Thyroid Eye Disease

NCT05776121

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Beijing Tongren Hospital, CMU Beijing, China
  • Peking University Third Hospital Beijing, China
  • Third Xiangya Hospital of Central South University Changsha, China
View Trial Details
Completed

A Study to Evaluate the Safety, Preliminary Efficacy, and Pharmacokinetic Properties of LASN01 in Healthy Subjects and in Patients With Pulmonary Fibrosis or Thyroid Eye Disease

NCT05331300

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +19 more
Locations
  • Site AU05 Hurstville, New South Wales, Australia
  • Site AU03 Brisbane, Queensland, Australia
  • Site AU01 Melbourne, Victoria, Australia
  • Site HK01 Shatin, Hong Kong
View Trial Details
Completed

Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study

NCT03298867

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +13 more
Locations
  • Macro, Llc Beverly Hills, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • The Lennar Foundation Medical Coral Gables, Florida, United States
  • Bascom Palmer Eye Institute Miami, Florida, United States
View all 14 locations
View Trial Details
Completed

A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease

NCT04583735

Conditions
Autoimmune Diseases, Behavior, Bronchial Diseases, +25 more
Locations
  • The Private Practice of Raymond Douglas Beverly Hills, California, United States
  • Perlman Medical Offices / UCSD La Jolla, California, United States
  • MACRO Trials Los Angeles, California, United States
  • Univ of Colorado Dept of Ophthalmology Aurora, Colorado, United States
View Trial Details
Completed

Treatment of Graves' Orbitopathy to Reduce Proptosis With Teprotumumab Infusions in an Open-Label Clinical Extension Study

NCT03461211

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Macro, Llc Beverly Hills, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Bascom Palmer Eye Institute Miami, Florida, United States
  • Kellogg Eye Center at University of Michigan Ann Arbor, Michigan, United States
View all 13 locations
View Trial Details
Completed

A Study of TEPEZZA® Treatment in Participants With Thyroid Eye Disease

NCT06389578

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Bascom Palmer Eye Institute - University of Miami Miami, Florida, United States
  • Barnes Jewish Hospital Washington University St Louis, Missouri, United States
  • Neuro-Eye Clinical Trials Bellaire, Texas, United States
View Trial Details

Related conditions